Zumutor is a leading Immuno Oncology company in the space of NK cell therapeutics
Bengaluru, India
Joined May 2019
- Tweets55
- Following30
- Followers141
- Likes154
Onward and forward!
Zumutor gets a PIND approval for ZM008, marches firmly towards the next regulatory milestone!
yourstory.com/2022/07/zumuto…
ZM008 one step closer to clinic
linkedin.com/posts/zumutor_a…
Funding Alert!
We have raised a series A4 round of $6.2Mil$!
This will propel further development to IND and First in human!
@accelindia
@bharat_fund
siana capital
m.economictimes.com/tech/fun…
Our Director @sunitmaity will speak about Biosimilar and Novel Biologics, in this virtual Symposium
Join us for our Virtual Symposium on Biologics & Novel Therapeutic Modalities!
📅Dec.13, 2021
⏰2PM Central Europe / 6:30PM India/ 9PM China / 8AM USA ET
Free registration at attendee.gotowebinar.com/reg…
More info at bit.ly/biologics2021
#biologics #antibodies #pharma #chembio
Do join the Webinar when our CEO Ms kavitha Iyer Rodrigues discusses her experience and challenges in setting up to scaling business in Healthcare Sector
Registration Link: bit.ly/3hDjwkI
#BharatInnovationFund
#IlluminaForStartups
Association of Biotechnology-Led Enterprises (ABLE) @able_indiabio has constituted a nine-member executive council that was elected last January for a three-year term starting on April 1, 2021.
biovoicenews.com/g-s-krishna…
Excited to share a feature in this edition of Biospectrum that has Zumutor’s CEO-Kavitha Iyer Rodrigues bag the entrepreneur of the year 2020 award!
This is a validation of consistent work @ Zumutor.
#Immunology
#noveltherapeutics
#zumutor
Listen from our CEO @IyerRodrigues when she speaks about her amazing journey at CII Startathon 2020
#startathon
This Post is from an account that no longer exists. Learn more
Biotechnology landscape in India as published in public domain where #Zumutor is mentioned. Data accuracy has not been validated but useful information.
youtu.be/_ovJYtcFefg
Another feather in Zumutor’s cap - our Founder- CEO, Kavitha Iyer Rodrigues was awarded the “ Woman Entrepreneur of the year 2020 “ in SMART Bio Awards Category by the Dept of IT/ BT and S&T, Govt of Karnataka
@drashwathcn @itbtgok @kbitsMd @ktech_bfc @Startup_Kar @IyerRodrigues
Watch our CEO Ms Kavitha Iyer Rodrigues @IyerRodrigues has to say about Bengaluru tech Summit @blrtechsummit
Watch Ms. @IyerRodrigues, Founder & CEO, @zumutor highly praise the #BTS2020 and looks forward to seeing various right minded individuals share their valuable insights and get a chance to collaborate with eachother.
#NextIsNow
We have received the grant from #USISTEF for Covid therapeutics development. It's a collaborative project in partnership with Prof Shiladitya Sengupta
#COVID19
#antibodylibrary
zumutor.com/2020/09/zumutor-…
Are you looking for a new Antibody sequence? Please check our INABLRS antibody discovery platform
zumutor.com/2020/08/inablrs-…
Zumutor Biologics retweeted
We are excited to share that Zumutor Biologics in partnership with Prof Shiladitya Sengupta of Harvard Med has been shortlisted by USIST Endowment Board for development of monoclonal antibody therapeutics for COVID 19.
#COVID19
#therapeutics
We are excited to share that Zumutor Biologics in partnership with Prof Shiladitya Sengupta of Harvard Med has been shortlisted by USIST Endowment Board for development of monoclonal antibody therapeutics for COVID 19.
#COVID19
#therapeutics
We're excited of being considered as a key player in the Global Next-Generation Bio-Therapeutic Market study conducted by @DBMROfficial.
#novel_biologics
#immuno_oncology
go.ciie.co/338JLZL
A strategic departure from the biotech incubator requires the coordination....listen it from our CEO Ms. Kavitha Iyer Rodrigues
#Zumutor
This Post is from an account that no longer exists. Learn more
The pandemic has imposed severe constraints not only on R&D but also on interactions with our SAB. A big thanks to SAB members for making the connect today - the whole board.
We hope to get ZM008 develpment on track for IND submission and Phase 1 trials.
#immuno_oncolgy
#mAb
We leverage our biologics expertise, cross functional team resources and state-of-the-art infrastructure to create value for partner's portfolio, get in touch with us.
#bespoke_service
